J

[J @jegpears]

Volpato could earn himself an Italy call-up if he keeps playing like that
#usaaus #worldcup

[J @jegpears]

@coughlin582 Oh go on Christina, treat us to an intra-day RNS like it’s 19-20-20!
Looking for forward to next week 😁 #avct

[J @jegpears]

@Cumulus51896691 @RAH00084 Never doubt that a small group of thoughtful, committed investors could perceive the changing world, indeed, it is the only thing that ever has #avct

[asininityandbeyond @asininitybeyond]

@BigBiteNow This stood out to me too:

“Funding beyond inflection points” - #AVCT now has negotiating strength.

“Substantial interest” - BP is motivated.

“Multiple parties” - there is competition.

“Partnering” - deal optionality.

Plus, “100% ownership” ⬇️ - ‘partners’ want the lot?

[J @jegpears]

How to RNS the currently unRNSable and a nod to retail: fill up your ISAs.
I think this is it - Avacta are the most primed for take-over that they’ve ever been and possibly ever will be. Data room invitees seeing The Beast at work x Avacta still insanely low market cap. #avct

[Avacta @avacta]

We are pleased to invite colleagues and investors to our 2026 Science Day: The Next Chapter of pre|CISION. Join us in Central London on May 6 at the Royal Society of Chemistry for presentations followed by a reception. https://t.co/1guKSV8aDY #AVCT

[J @jegpears]

@tom_the_bomb__ Too soon for early human data to be published?

[J @jegpears]

Fantastic news ahead of World Cancer Day tomorrow. Great work #AVCT

[Avacta @avacta]

Avacta has published two key clinical updates to its faridoxorubicin (AVA6000) clinical program. https://t.co/PKaWzT8fLX #AVCT

[J @jegpears]

Loving the scientific progress at #avct but wish they’d sell just one grape from the vineyard to get this moving 📈

[J @jegpears]

@PJ_Crabb @avacta @hughesy0707 would've been at a premium < 3 weeks ago. I think it's fair Paul

[J @jegpears]

@asininitybeyond @111BEN_111 Anything to read into the study number referencing 6k? #avct

[J @jegpears]

@JStonker As soon as I saw the farinose footnote my mind said, ‘release Stonks!’.
Great work mate #avct

[J @jegpears]

My prediction:
I think the #avct SP will drift back to 40p from now until end of Sept UNLESS we get some additional/exceptional news.. e.g. accelerated approval.
From Oct it will gather momentum leading up to ESMO where I hope/expect a first partnership is announced.
Top up time.

[J @jegpears]

#avct share price exhibiting a minor response today with a partial response expected within the week.
In the industry we call this: Progression, Free, Revival!

[J @jegpears]

@jivetur88775834 @111BEN_111 Takeda? #avct

[J @jegpears]

@111BEN_111 Sounds like we really could’ve done with her CFO experience. Disappointing

[J @jegpears]

@Tom_The_Bomb__ Have they invested under the proviso that David and Richard sit on the board?

[J @jegpears]

#avct

[J @jegpears]

@RAH00084 A shame it was written so negatively with no inference of the meaning.

[J @jegpears]

@Dapstergo @Tom_The_Bomb__ @AndrewDigby3 @avacta @coughlin582 FDA fast track is the holy grail of funding #avct

[J @jegpears]

CC (~9min): “Maybe it’s a Pre|CISION thing”
#avct nonchalantly curing cancer.
Now please turn this SP around 🙏

[Avacta @avacta]

In this episode of the R&D Spotlight Series we look at some of the new science ongoing on at Avacta, specifically around our second asset that will go into the clinic, AVA6103. We also discuss how AI is being leveraged to optimise patient populations https://t.co/F1GHwDlAyu #AVCT